ConductScience.org, home

Library / Genes

CXCR6: C-X-C motif chemokine receptor 6

1 protein, 152 patents, 0 drugs, 0 trials, 10,231 NIH grants and 17,436 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCXCR6HGNC
NameC-X-C motif chemokine receptor 6HGNC
NCBI Gene ID10663NCBI Gene
HGNC IDHGNC:16647HGNC
EnsemblENSG00000172215NCBI Gene
AliasesBONZO, CD186, CDw186, STRL33, TYMSTRNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
O00574C-X-C chemokine receptor type 63420Ensembl, GeneID, HGNCUniProt

Patents 152

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4724076 A22026-04-1566O00574Espacenet
JP 2026062654 A2026-04-1033O00574Espacenet
JP 2026004568 A2026-01-1441098O00574Espacenet
JP 2026004568 A2026-01-1441099O00574Espacenet
JP 2026004568 A2026-01-1441100O00574Espacenet
JP 2026004568 A2026-01-1441101O00574Espacenet
EP 4641202 A22025-10-29223O00574Espacenet
JP 2025147176 A2025-10-0616714O00574Espacenet
JP 2025529142 A2025-09-041165O00574Espacenet
US 12371689 B22025-07-291165O00574Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 10231

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant422,025NIH's project files
P30CA016672Cancer Center Support Grant342,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award192,025NIH's project files
U19AI082630Durable Alteration of the Human Immune system after Infection or Immunotherapy152,025NIH's project files
P30CA006973Regional Oncology Research Center132,025NIH's project files
P30DK043351Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital132,025NIH's project files
P30CA016058Cancer Center Support Grant122,025NIH's project files
P30CA068485Cancer Center Support Grant122,025NIH's project files
P51OD011132Emory National Primate Research Center122,025NIH's project files
R01EY011500Structure-function studies of visual arrestin122,025NIH's project files

Papers 17436

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42819213PubTator, text miningPubMed
42818637PubTator, text miningPubMed
42810331PubTator, text miningPubMed
42805762PubTator, text miningPubMed
42803357PubTator, text miningPubMed
42802210PubTator, text miningPubMed
42801640PubTator, text miningPubMed
42800553PubTator, text miningPubMed
42794738PubTator, text miningPubMed
42793257PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license